Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the âaffordable healthcare capital of the worldâ but would also be a massive growth engine for the country.
Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the âaffordable healthcare capital of the worldâ but would also be a massive growth engine for the country. ...
More Stories
Ola#39;s Bhavish Aggarwal looks to disrupt India#39;s EV market by mass producing vehicles
Warburg Pincus arm to invest Rs 800 crore for 0.49% stake in Adani Ports
NHAI cautions against sale of fake FASTags online; here#39;s what you need to do